![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 22, 19439-19447, May 31, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
From the The insulin receptor substrates (IRSs) are key
components in signaling from the insulin receptor, and consequently any
proteins that interact with them are expected to participate in insulin signaling. In this study we have searched for proteins that interact with IRS-4 by identifying the proteins that coimmunoprecipitated with
IRS-4 from human embryonic kidney 293 cells by microsequencing through
mass spectrometry. A group of proteins was found. These included
phosphatidylinositol 3-kinase, a protein previously identified as
an IRS-4 interactor, and several proteins for which there was no
previous evidence of IRS-4 association. One of these proteins, named
IRAS, that had been found earlier in another context was examined in
detail. The results from the overexpression of IRAS, where its amount
was about the same as that of IRS-4, indicated that IRAS associated
directly with IRS-4 and showed that the increased complexation of IRS-4
with IRAS did not alter the insulin-stimulated tyrosine phosphorylation
of IRS-4 or the association of IRS-4 with phosphatidylinositol
3-kinase or Grb2. On the other hand, overexpression of IRAS enhanced
IRS-4-dependent insulin stimulation of the
extracellularly regulated kinase. The domains of IRAS and IRS-4
responsible for the association of these two proteins were identified,
and it was shown that IRAS also associates with IRS-1, IRS-2, and
IRS-3.
Department of Biochemistry, Dartmouth
Medical School, Hanover, New Hampshire 03755, the
§ Microchemistry and Proteomics Analysis Facility,
Department of Molecular and Cellular Biology, Harvard University,
Cambridge, Massachusetts 02138, and the ¶ Departments of
Psychiatry, Pharmacology, and Physiology, University of Mississippi
Medical Center, Jackson, Mississippi 39216
To whom correspondence should be addressed: Dept. of
Biochemistry, Vail Bldg., Dartmouth Medical School, Hanover, NH 03755. Tel.: 603-650-1627; Fax: 603-650-1128; E-mail:
gustav.e.lienhard@dartmouth.edu.
This article has been cited by other articles:
![]() |
M. O. Hoque, M. S. Kim, K. L. Ostrow, J. Liu, G. B. A. Wisman, H. L. Park, M. L. Poeta, C. Jeronimo, R. Henrique, A. Lendvai, et al. Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome Cancer Res., April 15, 2008; 68(8): 2661 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wauman, A.-S. De Smet, D. Catteeuw, D. Belsham, and J. Tavernier Insulin Receptor Substrate 4 Couples the Leptin Receptor to Multiple Signaling Pathways Mol. Endocrinol., April 1, 2008; 22(4): 965 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-P. Lim and W. Hong Human Nischarin/Imidazoline Receptor Antisera-selected Protein Is Targeted to the Endosomes by a Combined Action of a PX Domain and a Coiled-coil Region J. Biol. Chem., December 24, 2004; 279(52): 54770 - 54782. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hinsby, J. V. Olsen, and M. Mann Tyrosine Phosphoproteomics of Fibroblast Growth Factor Signaling: A ROLE FOR INSULIN RECEPTOR SUBSTRATE-4 J. Biol. Chem., November 5, 2004; 279(45): 46438 - 46447. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Mihindukulasuriya, G. Zhou, J. Qin, and T.-H. Tan Protein Phosphatase 4 Interacts with and Down-regulates Insulin Receptor Substrate 4 following Tumor Necrosis Factor-{alpha} Stimulation J. Biol. Chem., November 5, 2004; 279(45): 46588 - 46594. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. PILETZ, G WANG, and H ZHU Cell Signaling by Imidazoline-1 Receptor Candidate, IRAS, and the Nischarin Homologue Ann. N.Y. Acad. Sci., December 1, 2003; 1009(1): 392 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. DONTENWILL, J. E. PILETZ, M. CHEN, J. BALDWIN, G. PASCAL, P. RONDE, L. DUPUY, H. GRENEY, K. TAKEDA, and P. BOUSQUETD IRAS Is an Anti-Apoptotic Protein Ann. N.Y. Acad. Sci., December 1, 2003; 1009(1): 400 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. MUSGRAVE, F. DEHLE, and J PILETZ Assembly of PRR-Containing Receptors on Scaffolds: A Model for Imidazoline I1-Receptor Action Ann. N.Y. Acad. Sci., December 1, 2003; 1009(1): 413 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Velliquette and P. Ernsberger The Role of I1-Imidazoline and {alpha}2-Adrenergic Receptors in the Modulation of Glucose Metabolism in the Spontaneously Hypertensive Obese Rat Model of Metabolic Syndrome X J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 646 - 657. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |